首页> 中文期刊> 《临床外科杂志》 >18F-FDG PET/CT显像在非小细胞肺癌预后评估中的应用

18F-FDG PET/CT显像在非小细胞肺癌预后评估中的应用

         

摘要

Lung cancer is one of the important causes of human death among the malignant tumors, in which non-small cell lung cancer accounts for about 85%. The treatment of lung cancer is complex. How to predict the prognosis of lung cancer is very important to choose better therapy methods. The traditional prognostic evaluation methods have some disadvantages. With the development of new technology, 18F-FDG PET/CT is applied to stage and re-stage, evaluate therapy effect and predict the prognosis of lung cancer. In this review, the prognosis effect of non-small cell lung cancer via 18F-FDG PET/CT will be discussed.%肺癌是恶性肿瘤中导致人类死亡的重要原因之一,非小细胞肺癌占其中的85%,其治疗手段多样复杂.如何更好的预测患者预后,对患者治疗方案的选择尤为重要.传统预后评估方法有一定的弊端.随着新技术的发展,18F-FDG PET/CT显像更多地应用于肺癌的分期及再分期、疗效评估和预测预后.本文对18F-FDG PET/CT显像定量指标在非小细胞肺癌预后评估中的应用进行综述.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号